What is Gene By Gene?
Gene By Gene, operating within the genomics and healthcare technology sector, is focused on leveraging advanced data analytics and reporting solutions. The company's core offering, the Clinical Reporting Application, is designed to revolutionize the management of clinical reports. By seamlessly integrating analysis data with electronic lab ordering and results distribution, GenomX empowers healthcare providers and clinicians to enhance productivity and reduce operational costs. The platform's commitment to data security, through HIPAA-compliant cloud storage, and its customizable features, including user-friendly dashboards, position it as a critical tool for modern healthcare practices. The company's objective is to facilitate the efficient sharing of patient lab reports among multiple clinicians, thereby improving patient care coordination and outcomes.
How much funding has Gene By Gene raised?
Gene By Gene has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Gene By Gene
PPP
Public-Private Partnership
What's next for Gene By Gene?
The recent major strategic investment in Gene By Gene signals a pivotal moment for the company, likely enabling accelerated expansion of its technological capabilities and market reach. This capital infusion is expected to fuel further development of its Clinical Reporting Application, potentially incorporating AI-driven insights or expanding into new therapeutic areas. The company's focus on streamlining clinical report management and enhancing data sharing positions it to capitalize on the growing demand for efficient, secure, and integrated healthcare IT solutions. Future growth may involve strategic partnerships with larger healthcare systems or further rounds of financing to support global scaling efforts.
See full Gene By Gene company page
